119 results
8-K
EX-10.1
OCUP
Ocuphire Pharma Inc
5 Dec 23
Departure of Directors or Certain Officers
7:15pm
) during which the Executive was employed by the Company in the calendar year of 2023.
(iii) Long-Term Incentive Compensation. Beginning in 2023 … or other equity based long-term incentive compensation plan, program or arrangement (the “Plans”) generally made available to senior executive officers
8-K
EX-99.1
iwa9nuwlq
2 Nov 23
Ocuphire Corporate Presentation November 2023
8:44am
8-K
EX-10.1
gund 48n6takz
1 Nov 23
Ocuphire Pharma Announces Appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and Director
4:21pm
424B5
smbfm82s2u9js2
14 Aug 23
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
hcwjfn
1 Aug 23
Restore Vision & Clarity Ocuphire Corporate Presentation August 2023
11:21am
8-K
EX-99.1
g9cr5c0qy
30 Mar 23
Ocuphire Pharma Announces Financial Results for Fourth Quarter and Year Ended 2022 and Provides Corporate Update
9:05am
8-K
EX-99.2
g7pfd762fam3h13 g2c
12 Aug 22
Ocuphire Pharma Announces Financial Results for the Second Quarter 2022 and Provides Corporate Update
7:51am